Endoscopic management has become an effective method to repair proximal hamstring injuries. However, due to the complexity of such a procedure, the dissemination of the technique of endoscopic hamstring repair has occurred slowly among orthopaedic surgeons. This Technical Note with a video modifies previously described techniques and provides safer and more simplified endoscopic management of proximal hamstring injuries.
Recently, attention has been given to recalcitrant lateral hip pain, also known as greater trochanteric pain syndrome. Although, historically, this has been attributed to greater trochanteric bursitis, the literature has shown that many patients will have a lesion of the gluteus medius and minimus tendons. Endoscopic hip abductor tendon repair has been shown to provide good outcomes with decreasing overall morbidity and is becoming more popular. However, failure rates have been reported to be as high as 35%, likely due to the poor tissue quality in this older population. Acellular human dermal allograft has been used to augment rotator cuff repairs in an attempt to improve tendon healing. The technique described in this Technical Note shows endoscopic gluteus medius and minimus repair with acellular human dermal allograft augmentation focusing on graft preparation, implantation, and fixation in a safe and reproducible manner.
Background:The quadriceps tendon is becoming a popular graft option for anterior
cruciate ligament (ACL) reconstruction. Few studies have examined the
biomechanics of the quadriceps tendon compared with more commonly used graft
choices. Due to the risk associated with small-diameter hamstring tendon
grafts, various modifications of hamstring tendon preparation techniques
have been described—specifically, a tripled, 6-strand hamstring tendon
construct. This is the first study to directly compare the biomechanical
properties of quadriceps tendon and hamstring tendon grafts.Purpose/Hypothesis:The purpose of this study was to quantify the biomechanical properties of the
quadriceps tendon and 6-strand hamstring tendon grafts, specifically
evaluating ultimate load to failure, load at 3 mm of displacement, and
stiffness. These parameters characterize the time zero, in vitro, static
tensile properties of these graft options. Our hypothesis was that for
grafts of similar size, there would not be a significant difference in the
biomechanical properties.Study Design:Controlled laboratory study.Methods:Quadriceps and hamstring tendon grafts were harvested from 6 human cadaveric
knees (mean age, 61.17 ± 10.38 years). These matched grafts were prepared
and biomechanically tested using an all-electric dynamic test load system.
The mean diameter, stiffness, ultimate load to failure, and load to 3 mm of
displacement were evaluated and analyzed.Results:The mean diameters of the 6-strand hamstring and quadriceps tendons were
11.33 and 10.16 mm, respectively (P = .03). Despite these
significantly different diameters, no differences were found in graft
ultimate load to failure or load at 3 mm of displacement. The 6-strand
hamstring tendon graft was significantly stiffer compared with the
quadriceps tendon (1147.65 vs 808.65 N/mm; P = .04).Conclusion:The 6-strand hamstring tendon and quadriceps tendon graft had similar
biomechanical properties with respect to ultimate load to failure and load
at 3 mm of displacement in 6 matched cadaveric specimens. Both grafts were
significantly stiffer than the native ACL, and the hamstring tendon
construct was significantly stiffer than the quadriceps tendon.Clinical Relevance:The quadriceps tendon graft is a reliable alternative to a 6-strand hamstring
tendon graft for ACL reconstruction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.